Biomerica/$BMRA
13:30
14:25
15:15
16:10
17:00
1D1W1MYTD1Y5YMAX
About Biomerica
Biomerica Inc is engaged in the development, manufacturing, and marketing of medical diagnostic products designed for the early detection and monitoring of chronic diseases and medical conditions. The company focuses on products for gastrointestinal diseases, food intolerances, diabetes, and certain esoteric tests. It operates in one segment namely, the design, development, marketing and sales of diagnostic kits. The majority of the company's revenue is earned from the Asia, and also has its presence in Europe, North America, Middle East and South America.
Ticker
$BMRA
Sector
Primary listing
Industry
Health Care Equipment & Supplies
Headquarters
Employees
-
ISIN
US09061H4065
Website
Biomerica Metrics
BasicAdvanced
$8.3M
-
-$2.14
0.37
-
Price and volume
Market cap
$8.3M
Beta
0.37
52-week high
$4.21
52-week low
$2.88
Average daily volume
47K
Financial strength
Current ratio
3.762
Quick ratio
2.623
Long term debt to equity
3.488
Total debt to equity
9.812
Profitability
EBITDA (TTM)
-5.015
Gross margin (TTM)
13.42%
Net profit margin (TTM)
-85.42%
Operating margin (TTM)
-89.84%
Effective tax rate (TTM)
-0.06%
Management effectiveness
Return on assets (TTM)
-35.99%
Return on equity (TTM)
-72.70%
Valuation
Price to revenue (TTM)
1.308
Price to book
1.5
Price to tangible book (TTM)
1.57
Price to free cash flow (TTM)
-1.733
Free cash flow yield (TTM)
-57.70%
Free cash flow per share (TTM)
-188.68%
Growth
Revenue change (TTM)
5.01%
Earnings per share change (TTM)
-29.29%
3-year revenue growth (CAGR)
-27.05%
10-year revenue growth (CAGR)
0.99%
3-year earnings per share growth (CAGR)
-9.20%
10-year earnings per share growth (CAGR)
15.97%
Biomerica News
AllArticlesVideos
InFoods IBS receives CPT® Proprietary Laboratory Analysis (PLA) Code
GlobeNewsWire·2 days ago
Clinical Diagnostics Industry Leader Scott Madel Joins Biomerica's Team as Chief Commercial Officer
GlobeNewsWire·1 week ago
Biomerica Appoints Eric B. Chin to Board of Directors and Audit Committee Chair
GlobeNewsWire·4 weeks ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Biomerica stock?
Biomerica (BMRA) has a market cap of $8.3M as of July 04, 2025.
What is the P/E ratio for Biomerica stock?
The price to earnings (P/E) ratio for Biomerica (BMRA) stock is 0 as of July 04, 2025.
Does Biomerica stock pay dividends?
No, Biomerica (BMRA) stock does not pay dividends to its shareholders as of July 04, 2025.
When is the next Biomerica dividend payment date?
Biomerica (BMRA) stock does not pay dividends to its shareholders.
What is the beta indicator for Biomerica?
Biomerica (BMRA) has a beta rating of 0.37. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.